Real-time enrollment status for this metastatic colorectal cancer (crc) clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 9:52 AM UTC
| NCT Number | NCT07228832 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Colorectal Cancer (CRC) |
| Phase | PHASE3 |
| Target Enrollment | 600 participants |
| Active Locations | 94 sites in the US |
| Sponsor | Summit Therapeutics |
| Last Updated on CT.gov | August 4, 2026 (3 weeks ago) |
As of August 27, 2026: Clinical trial NCT07228832 is currently recruiting participants. This phase3 study for metastatic colorectal cancer (crc) is actively seeking new participants at 94 locations across the United States. The study is sponsored by Summit Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07228832 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 94 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07228832 was last updated 3 weeks ago (August 4, 2026). HelloStudys verifies this status automatically.